Evidence map›Paper›PMID 41050738›Full record

ReviewNew microbes and new infections2025

Evidence of

Mina Latifian, Fahimeh Bagheri Amiri, Ehsan Mostafavi, Saber Esmaeili

Abstract readReview
In one paragraph

Review in New microbes and new infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mina LatifianNational Reference Laboratory for Plague, Tularemia and Q Fever, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Akanlu, Kabudar Ahang, Hamadan, Iran.
Fahimeh Bagheri AmiriWHO Collaborating Centre for Vector-Borne Diseases, Department of Epidemiology and Biostatics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.
Ehsan MostafaviNational Reference Laboratory for Plague, Tularemia and Q Fever, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Akanlu, Kabudar Ahang, Hamadan, Iran.
Saber EsmaeiliNational Reference Laboratory for Plague, Tularemia and Q Fever, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Akanlu, Kabudar Ahang, Hamadan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Q fever infection in pregnant women and its complications have been neglected in the world and little attention has been paid to it by health systems. Therefore, this study aimed to provide evidence regarding the association between Q fever infection and its effects on human abortion. Methods: English electronic data sources were searched including PubMed and Web of Science from 1993 to December 2024; the search strategy was implemented using these keywords (in the title/abstract) were used: " Results: In this review, 30 papers of 705 candidate articles obtained from two databases, were considered for meta-analysis. The overall seroprevalence of Conclusions: According to the results, the seroprevalence of Q fever among pregnant women, especially women who have a history of abortion, is significant and requires more investigations by the health providers. Active surveillance and further studies are recommended to more clearly define the epidemiology and significance of Prospero registration number: CRD42023402863.

Indexed as

AbortionCoxiella burnetiiPregnancyQ feverWomen

Identifiers

PMID41050738
PMCPMC12491684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.